Top Markets
Coin of the day
PaxMedica, Inc. Common Stock PaxMedica, Inc. Common Stock

PaxMedica, Inc. Common Stock

PXMD
Rang în acțiuni #40911
PaxMedica, Inc. is a biopharmaceutical company currently in the clinical... PaxMedica, Inc. is a biopharmaceutical company currently in the clinical development phase, dedicated to advancing anti-purinergic drug therapies (APTs). These innovative treatments are specifically designed to address complex neurological disorders presenting with stubborn and persistent symptoms. The company's primary investigative drug is PAX-101, an intravenous (IV) form of suramin, which is being explored for a variety of conditions. These include autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, post-COVID-19 syndrome (commonly known as "long COVID"), and human African trypanosomiasis. Furthermore, PaxMedica is also developing PAX-102, an intranasal version of suramin, intended for various neurological applications. The company, which was incorporated in 2018 and has its headquarters in Tarrytown, New York, previously operated as Purinix Pharmaceuticals LLC before rebranding to PaxMedica, Inc. in April 2020. It functions as a subsidiary of Tardimed Sciences LLC.
Preț acțiune
$0.0005
Ultima sincronizare: 2026-08-12
Capitalizare de piață
$63.13K
Schimbare (1 zi)
0.00%
Schimbare (1 an)
150.00%
Țară
US
Tranzacționează PaxMedica, Inc. Common Stock (PXMD)

Categorie

Istoric al prețului acțiunii pentru PaxMedica, Inc. Common Stock (PXMD)
Cel mai mare preț de închidere: $0.00 pe 2026-08-01

Cel mai mic preț de închidere: $64.98 pe 2022-08-01
Istoric al prețului acțiunii pentru PaxMedica, Inc. Common Stock din 2022 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 0.00%
2025 -99.67%
2024 -90.14%
2023 -97.74%
2022 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$522.05 31.86%
US
$863.30 33.51%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE